Research Study
View Full Study →
Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.
Citation
Oknińska M., El-Hafny-Rahbi B., Paterek A., Mackiewicz U., Crola-Da Silva C. et al. (2021). Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.. J Cell Mol Med. DOI: 10.1111/jcmm.14909
Abstract
Abstract not available. See citation for source.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.